CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0200
-0.0100 (-33.33%)
Aug 17, 2026, 3:30 PM EST

CV Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12.7413.7915.711616.2120.05
Revenue Growth
-14.90%-12.20%-1.87%-1.24%-19.17%-17.93%
Gross Profit
6.266.757.177.095.558.62
Operating Income
-0.97-0.47-1.373.61-8.13-13.41
Net Income
-2.01-0.96-2.393.1-10.05-15.55
Earnings Per Share
-0.01-0.01-0.010.02-0.07-0.14
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.270.280.451.320.611.38
Total Debt
1.2520.780.441.530.92
Net Cash (Debt)
-0.99-1.72-0.330.88-0.920.45
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.000.01-0.010.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.49-0.41-0.862.25-1.89-7.49
Capital Expenditures
-0.03-0.11-0.02---0.04
Free Cash Flow
-0.52-0.52-0.882.25-1.89-7.52
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.14%48.97%45.64%44.27%34.25%42.98%
Operating Margin
-7.60%-3.41%-8.75%22.56%-50.16%-66.90%
Pretax Margin
-15.69%-6.88%-15.29%19.35%-56.66%-78.02%
Profit Margin
-15.74%-6.95%-15.24%19.38%-62.04%-77.58%
FCF Margin
-4.10%-3.74%-5.60%14.08%-11.63%-37.51%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---1.76--
Forward PE
-5.705.705.705.705.70
P/FCF Ratio
---2.43--
PS Ratio
0.320.820.400.340.310.65